4 minute read
Oct. 29, 2022

GST-HG131: an Oral Hepatitis B Virus (HBV) Inhibitor


oral HBV antigen inhibitor Ph. I candidate for hepatitis B SAR opt. of a previously disclosed inhibitor Bioorganic Med. Chem. Lett., Sep 8, 2022 WuXi AppTec, Shanghai, CN

Drug Hunter Team

GST-HG131 (WuXi AppTec) is an oral hepatitis B virus (HBV) inhibitor which lowers hepatitis B antigen (HBsAg) levels which entered clinical development in Chinese subjects for chronic hepatitis B infection. Despite the significant research strides made in the elucidation of the biology of HBV, chronic HBV infection continues to [...]



Other molecules you may be interested in